[CHEMO-ANTIBIOTIC THERAPY OF TUBERCULOSIS IN DIABETICS AND ITS REPERCUSSIONS ON GLUCIDE METABOLISM].
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D001786:Blood Glucose; D050260:Carbohydrate Metabolism; D003523:Cycloserine; D003920:Diabetes Mellitus; D004361:Drug Tolerance; D005000:Ethionamide; D006801:Humans; D007538:Isoniazid; D007612:Kanamycin; D010600:Pharmacology; D011718:Pyrazinamide; D012294:Rifamycins; D013307:Streptomycin; D013882:Thiosemicarbazones; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D001786:Blood Glucose; D012294:Rifamycins; D013882:Thiosemicarbazones; D011718:Pyrazinamide; D007612:Kanamycin; D010131:Aminosalicylic Acid; D003523:Cycloserine; C023808:rifamycin SV; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
AMINOSALICYLIC ACID; ANTITUBERCULAR AGENTS; BLOOD SUGAR; CARBOHYDRATE METABOLISM; CYCLOSERINE; DIABETES MELLITUS; DRUG TOLERANCE; ETHIONIAMIDE; ISONIAZID; KANAMYCIN; PHARMACOLOGY; PYRAZINAMIDE; RIFOMYCIN; STREPTOMYCIN; THIOSEMICARBAZONES; TUBERCULOSIS, PULMONARY
LA TERAPIA CHEMIO-ANTIBIOTICA DELLA TUBERCOLOSI NEI DIABETICI E SUE RIPERCUSSIONI SUL RICAMBIO GLUCIDICO.